Patients with age-related macular degeneration who are new to treatment experience gains in vision and anatomical markers 6 months after starting high-dose aflibercept, a study shows.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/high-dose-aflibercept-shows-improvement-previously-untreated-2025a1000ost?src=rss
Author :
Publish date : 2025-09-18 13:54:00
Copyright for syndicated content belongs to the linked Source.
